Lind Global Fund II LP 13D and 13G filings for InVivo Therapeutics Holdings Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 8:09 pm Purchase |
2023-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ |
Lind Global Fund II LP | 125,520 3.900% |
125,520 (New Position) |
Filing |